BIO KEY INTERNATIONAL INC
Data quality: 83%
BKYI
Nasdaq
Technology
Software
$0.56
▼
$0.01
(-1.85%)
Mkt Cap: 6.09 M
Price
$0.56
Mkt Cap
6.09 M
Day Range
$0.55 — $0.57
52-Week Range
$0.49 — $1.97
Volume
55,740
Open $0.57
50D / 200D Avg
$0.62
10.21% below
50D / 200D Avg
$0.73
22.68% below
Quick Summary
Key Takeaways
Negative free cash flow of -3.35 M
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-65.96%
Below sector avg (1.74%)
ROIC-43.42%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
N/A
Current Ratio1.26
Interest Coverage-27.42
Valuation
PE (TTM)
-1.43
Below sector avg (-0.16)
P/B Ratio1.01
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Technology sector median (1058 peers)
Peer Comparison
vs Technology sector median (1058 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -1.4 | -0.2 |
| P/B | 1.0 | 3.0 |
| ROE % | -66.0 | 1.7 |
| Net Margin % | — | -0.6 |
| Rev Growth 5Y % | — | 7.2 |
| D/E | — | 0.4 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -4.25 M |
| ROE | -65.96% | ROA | -41.23% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -3.35 M |
| ROIC | -43.42% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 1.26 |
| Interest Coverage | -27.42 | Asset Turnover | N/A |
| Working Capital | 781,785 | Tangible Book Value | 5.16 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -1.43 | Forward P/E | N/A |
| P/B Ratio | 1.01 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -55.04% | ||
| Market Cap | 6.09 M | Enterprise Value | 4.05 M |
| Per Share | |||
| EPS (Diluted TTM) | N/A | Revenue / Share | N/A |
| FCF / Share | -0.31 | OCF / Share | -0.31 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 78.76% |
| SBC-Adj. FCF | N/A | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | -4.30 M | -8.52 M | -11.91 M | -5.07 M | -9.67 M |
| EPS (Diluted) | — | — | — | — | — |
| Gross Profit | 5.64 M | 1.43 M | 4.58 M | 3.44 M | 2.04 M |
| Operating Income | -4.01 M | -8.83 M | -9.92 M | -4.94 M | -4.47 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 2.51 M | 2.39 M | 3.25 M | 2.36 M | 1.40 M |
| SG&A Expenses | 7.14 M | 7.86 M | 9.36 M | 6.03 M | 5.85 M |
| D&A | 93,026.0 | 75,136.0 | — | — | — |
| Interest Expense | 175,755.0 | 218,270.0 | 10,462.0 | 18,000.0 | 4.34 M |
| Income Tax | -22,998.0 | -134,014.0 | 20,434.0 | 0.0 | 0.0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 8.62 M | 4.52 M | 11.34 M | 17.77 M | 22.52 M |
| Total Liabilities | 4.84 M | 3.45 M | 6.04 M | 2.15 M | 2.19 M |
| Shareholders' Equity | 3.77 M | 1.06 M | 5.30 M | 15.62 M | 20.34 M |
| Total Debt | 44,762.0 | 188,787.0 | 2.92 M | 0.0 | 232,000.0 |
| Cash & Equivalents | 437,604.0 | 511,400.0 | 2.64 M | 7.75 M | 16.99 M |
| Current Assets | 1.89 M | 2.62 M | 8.98 M | 14.01 M | 18.94 M |
| Current Liabilities | 4.55 M | 3.21 M | 5.46 M | 2.00 M | 1.88 M |
{"event":"ticker_viewed","properties":{"ticker":"BKYI","listing_kind":"stock","pathname":"/stocks/bkyi","exchange":"Nasdaq","country":"US"}}